AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccines Achieve Good Safety Results In Clinical Trials.(Brief Article)

Vaccine Weekly

| June 20, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 JUN 20 - (NewsRx.com & NewsRx.net) --

Vical Inc. (VICL) reviewed the safety data from its recent Allovectin-7(R) and Leuvectin(TM) clinical trials, along with results suggesting research directions to enhance patient immune response, at the June 2001 meeting of the American Society of Gene Therapy (ASGT) in Seattle, Washington.

Vical scientists also presented preclinical data showing improved naked DNA protein-expression levels through the use of electroporation and poloxamers, and improved immune response to naked DNA vaccines through the application of foreign epitopes.

John Gutheil, MD, Vical, gave an overview of the safety profile of naked DNA cancer vaccines Allovectin-7 and Leuvectin from 15 completed Vical clinical studies enrolling more than 560 patients.

"While most currently approved therapeutics for the cancers under study cause severe side effects in the majority of treated patients," he said, "Vical's treatments produced severe reactions in only 1% of treated patients. We believe naked DNA gene therapy may provide efficacy comparable to conventional therapies, while offering significant advantages in safety and tolerability for the patient."

Evan Hersh, MD, professor of medicine at ...

Related articles from newspapers, magazines, journals, and more
New Research Includes Use of Vical's 'Naked DNA' Technology for HIV Vaccine.
Press release article from: PR Newswire January 18, 2002 700+ words
...Nature describe the use of the Vical Incorporated "naked DNA" technology in the ongoing...to determine the role for Vical's naked DNA technology used in combination...statements about the role Vical's naked DNA technology may play in a vaccine...
Merck Licenses Vical's "Naked" DNA Technology to Deliver Certain Growth Factors.
Press release article from: Business Wire September 15, 1997 700+ words
...MRK) certain rights to use Vical's "naked" DNA technology to deliver certain...licenses and options to license Vical's naked DNA technology to deliver growth...marks the first license of Vical's naked DNA technology for potential delivery...
Vical Presents Naked DNA Enhancement Technologies; New Methods to Boost...
Press release article from: Business Wire June 4, 2000 700+ words
...The key discovery leading to Vical's patented naked DNA direct gene delivery technology...weeks to several months. Vical's naked DNA gene delivery approach involves...techniques. Since the discovery of naked DNA, Vical scientists have improved the...
Merck Confirms Use of Vical's Naked DNA Technology in HIV Vaccine Program.
Press release article from: PR Newswire April 2, 2001 700+ words
...prime-boost strategies using Vical's naked DNA delivery to prime the immune...adeno-associated viruses with Vical's naked DNA technology in the prime vaccine...exclusive worldwide license to Vical's naked DNA vaccine technology for HIV...
Vical Announces Positive Phase I/II Results With Naked DNA Cancer Vaccine.
Press release article from: PR Newswire March 27, 2001 700+ words
...PRNewswire/ -- Vical Incorporated...patient-specific naked DNA vaccine for low...these diagnoses. Vical Incorporated, The Naked DNA Company(TM...Cancer Institute, a naked DNA vaccine to treat...interested in any of Vical's clinical trials...
Vical and Merck expand naked DNA vaccine agreement. (Vical Inc., Merck &...
Newspaper article from: AIDS Weekly May 16, 1994 700+ words
Naked DNA Vical Inc. announced that Merck & Company...an option to an exclusive license to use Vical's proprietary gene-based vaccine technology...Collaboration and License Agreement with Vical, the Vical technology for use with two...
Vical Licenses Naked DNA Technology to Aventis Pharma for Growth Factor...
Press release article from: Business Wire July 6, 2000 700+ words
...NYSE:AVE), rights to use Vical's naked DNA gene transfer technology to...Aventis Pharma holds rights. Naked DNA is Vical's patented method for delivering...feeding the foot and lower leg. Vical Inc., The Naked DNA Company(TM), is focused...
Vical to Receive $1 Million Milestone Payment; Merck Initiates Naked DNA HIV...
Press release article from: Business Wire January 7, 2000 700+ words
...developing the vaccine using Vical's patented naked DNA gene delivery technology...also holds a license to use Vical's naked DNA technology for a therapeutic...eradication of the disease. Vical Inc., The Naked DNA Company(TM), is focused...
Vical and Pasteur Merieux Connaught expand naked DNA vaccine collaboration.
Press release article from: Business Wire May 8, 1996 700+ words
...WIRE)--May 8, 1996--Vical Incorporated (Nasdaq:VICL...Connaught) covering the use of Vical's proprietary ``naked'' DNA technology for DNA-based...take exclusive licenses to Vical's naked DNA vaccine technology for certain...
Vical to Begin Collaborative Naked DNA Safety and Efficacy Vaccine Trial for...
Press release article from: Business Wire August 22, 2000 700+ words
...multi-year contract with Vical for development work on a naked DNA vaccine to prevent malaria...technology is called "naked DNA" because the plasmids...the infectious agent. Vical Incorporated, The Naked DNA Company(TM), is focused...
For more facts and information, see all results

Source: HighBeam Research, Vaccines Achieve Good Safety Results In Clinical Trials.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA